Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 1/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | CASP6 | P55212 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 2/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.49 |
| ▸ | CDK2 | P24941 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HNF4A | P41235 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28660711 | 0.88 | HPRT1 (0.66) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL710252 | 0.86 | HPRT1 (1.00) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL11330582 | 0.86 | TDP1 (0.61) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL29450700 | 0.86 | HPRT1 (1.00) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL30878647 | 0.86 | HPRT1 (1.00) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| Charcoal, Activated SCHEMBL5052441 | 0.85 | HPRT1 (0.96) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL18600587 | 0.85 | HPRT1 (0.62) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL6245129 | 0.85 | HPRT1 (0.78) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL7918825 | 0.82 | HPRT1 (0.58) | HPRT1TDP1TSHRCASP6ALDH1A1 | |
| SCHEMBL30496200 | 0.81 | ALDH1A1 (0.61) | HPRT1TDP1TSHRCASP6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113960220-B | Synchronous detection method and application of polycyclic aromatic hydrocarbon and derivatives thereof in blood | 生态环境部华南环境科学研究所 | 2022-03-04 | — | — | CN | claimed |
| CN-113960220-A | Synchronous detection method and application of polycyclic aromatic hydrocarbon and derivatives thereof in blood | 生态环境部华南环境科学研究所 | 2022-01-21 | — | — | CN | claimed |
| CN-105203621-A | Application of nitrogen-doped carbon point to analysis of micro-molecular environmental pollutants | UNIV SHANXI | 2015-12-30 | — | — | CN | claimed |
| EP-4263724-B1 | PROCESS FOR PRODUCING CARBON BLACKS WITH REDUCED POLYCYCLIC AROMATIC HYDROCARBON CONTENT UTILIZING SUPERCRITICAL FLUID EXTRACTION | ORION ENG CARBONS IP GMBH & CO KG (DE) | 2026-04-15 | — | — | EP | disclosed |
| CN-121450637-A | Immobilized microbial inoculum and application thereof in carbon fixation and decontamination | 南京农业大学 | 2026-02-03 | — | — | CN | disclosed |
| US-20250268926-A1 | METHOD AND COMPOSITION FOR TREATING, ALLEVIATING OR PREVENTING A DISEASE OR CONDITION CAUSED BY AIR POLLUTANT | HONG KONG BAPTIST UNIVERSITY (CN) | 2025-08-28 | — | — | US | disclosed |
| US-20250241937-A1 | CANCER CELL PROLIFERATION SUPPRESSION AGENT AND COMPOSITION FOR SUPPRESSING PROLIFERATION OF CANCER CELLS | RESONAC CORPORATION (JP) | 2025-07-31 | — | — | US | disclosed |
| WO-2025124901-A1 | PROCESS FOR PRODUCING PURIFIED CARBON BLACKS WITH REDUCED CONTENT OF OXIDIZED POLYCYCLIC AROMATIC HYDROCARBONS | ORION ENGINEERED CARBONS IP GMBH & CO. KG (DE) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025098667-A1 | ALKALINE CARBON BLACK, PREPARATION THEREOF AND COMPOSITIONS AND ARTICLES CONTAINING THE SAME | ORION ENGINEERED CARBONS IP GMBH & CO. KG (DE) | 2025-05-15 | — | — | WO | disclosed |
| EP-4549505-A1 | ALKALINE CARBON BLACK, PREPARATION THEREOF AND COMPOSITIONS AND ARTICLES CONTAINING THE SAME | Orion Engineered Carbons GmbH (DE) | 2025-05-07 | — | — | EP | disclosed |
| EP-3970799-B1 | INOSITOL DERIVATIVE FOR SUPPRESSING PROLIFERATION OF CANCER CELLS | RESONAC CORP (JP) | 2024-12-11 | — | — | EP | disclosed |
| WO-2020230741-A1 | CANCER CELL PROLIFERATION SUPPRESSION AGENT AND COMPOSITION FOR SUPPRESSING PROLIFERATION OF CANCER CELLS | 昭和電工株式会社 | 2020-11-19 | — | — | WO | disclosed |
| CN-110215914-B | Zeolite imidazole framework material ZIF-8-based solid-phase microextraction fiber and preparation method and application thereof | 南京大学 | 2020-08-04 | — | — | CN | disclosed |
| CN-111138313-A | Schiff base compound with aggregation-induced emission characteristic and method for preparing ratiometric fluorescent probe by using Schiff base compound | 广东药科大学 | 2020-05-12 | — | — | CN | disclosed |
| CN-110231206-A | The pre-treating method of persistence organic pollutant in a kind of quick measurement Atmospheric particulates | 北京化工大学 | 2019-09-13 | — | — | CN | disclosed |
| CN-110215914-A | A kind of solid-phase micro-extraction fibre and the preparation method and application thereof based on zeolite imidazole skeleton material ZIF-8 | 南京大学 | 2019-09-10 | — | — | CN | disclosed |
| CN-105392778-A | Polycyclic compound and organic light emitting device using the same | HEESUNG MAT LTD | 2016-03-09 | — | — | CN | disclosed |
| CN-105203621-A | Application of nitrogen-doped carbon point to analysis of micro-molecular environmental pollutants | UNIV SHANXI | 2015-12-30 | — | — | CN | disclosed |
| US-5780250-A | Immunoassay standards for polyaromatic hydrocarbon detection | STRATEGIC DIAGNOSTICS, INC. (US) | 1998-07-14 | — | — | US | disclosed |
| WO-1997031267-A1 | IMMUNOASSAY STANDARDS FOR POLYAROMATIC HYDROCARBON DETECTION | STRATEGIC DIAGNOSTICS, INC. (US) | 1997-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250241937-A1 | CANCER CELL PROLIFERATION SUPPRESSION AGENT AND COMPOSITION FOR SUPPRESSING PROLIFERATION OF CANCER CELLS | MKI67, PPIP5K2, IMPA1 | HPRT1 710/4885TDP1 4048/4885TSHR 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.